[Form 4] Natera, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Matthew Rabinowitz, Executive Chairman and Director of Natera, Inc. (NTRA), reported sales of common stock under a pre-established trading plan. On 09/12/2025 the filing shows a total of 5,000 shares sold (4,500 and 500 shares) at prices reported as a weighted average of $170.3083 for one block and $172.64 for the other, with the larger block sold at prices ranging from $170.00 to $170.93. The Form states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
The filing lists 2,360,852 shares beneficially owned directly following the reported transactions. It also records indirect holdings attributed to a spouse of 25,500 and 25,000 shares on separate lines. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating pre-arranged trades rather than opportunistic insider timing
- Timely disclosure of transactions and remaining direct ownership (2,360,852 shares) in a filed Form 4
Negative
- None.
Insights
TL;DR: Routine insider sales under a 10b5-1 plan; disclosure aligns with standard governance practice.
The transactions disclosed are sales executed under a Rule 10b5-1 plan adopted on June 13, 2025, which indicates pre-arranged, time-based dispositions rather than opportunistic trading tied to contemporaneous material nonpublic information. The filing provides the number of shares sold (4,500 and 500), weighted average prices for the larger block and the explicit price for the smaller block, and the direct beneficial ownership remaining at 2,360,852 shares. From a governance perspective, use of a 10b5-1 plan and timely Form 4 reporting are consistent with compliance and insider trading controls.
TL;DR: Insiders sold 5,000 shares total; transaction size is small relative to reported direct holdings.
The combined sale of 5,000 shares on 09/12/2025 at average prices around $170–$173 represents a minor liquidity event compared with the reported direct beneficial ownership of 2,360,852 shares. The disclosure of the price range and weighted average adds transparency about execution. No derivative transactions or other compensatory equity events are reported on this Form 4. This is a routine disclosure with limited market impact based on the amounts shown.